Peter Charleson

Statistics

Publications

Citations

616

H-Index

Active since

1990

Affiliations

Merck Canada Inc. (Canada)(Current)

Peter Charleson is an author at Merck Canada Inc. (Canada) specializing in leukotriene biosynthesis, leukotriene synthesis inhibitors, and pharmacology.

Publications per year

1990–1992

Publications

Identification and isolation of a membrane protein necessary for leukotriene production

Douglas K. Miller, John W. Gillard, Philip J. Vickers et al. · Nature · 1990 · 462 citations

Life Sciences, Biochemistry, Molecular Biology +12

5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.

Jilly F. Evans, C Lévillé, Joseph A. Mancini et al. · Molecular Pharmacology · 1991 · 75 citations

Life Sciences, Medicinal Chemistry, Pharmacology +13

Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition.

S. Charleson, Petpiboon Prasit, Serge Léger et al. · Molecular Pharmacology · 1992 · 43 citations

Medicine, Biochemistry, Pharmacology +14

5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors.

Joseph A. Mancini, Petpiboon Prasit, Marc G. Coppolino et al. · Molecular Pharmacology · 1992 · 36 citations

Medicine, Medicinal Chemistry, Pharmacology +12

1–4 of 4